Cargando…
Clozapine re-challenge and initiation following neutropenia: a review and case series of 14 patients in a high-secure forensic hospital
OBJECTIVE: Clozapine remains the most effective intervention for treatment resistant schizophrenia; however, its use is prohibited following neutropenias. We review neutrophil biology as applied to clozapine and describe the strategies to initiate clozapine following neutropenia used in a case serie...
Autores principales: | Silva, Edward, Higgins, Melanie, Hammer, Barbara, Stephenson, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221694/ https://www.ncbi.nlm.nih.gov/pubmed/34221348 http://dx.doi.org/10.1177/20451253211015070 |
Ejemplares similares
-
Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide
por: Silva, Edward, et al.
Publicado: (2020) -
Two Patients with Schizophrenia Treated with Clozapine Developed Neutropenia After Receiving a COVID-19 Vaccine
por: Tomita, Tetsu, et al.
Publicado: (2022) -
Clozapine prescribing in COVID-19 positive medical inpatients: a case series
por: Butler, Matthew, et al.
Publicado: (2020) -
Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review
por: Oloyede, Ebenezer, et al.
Publicado: (2022) -
Late-onset neutropenia due to clozapine
por: Tatar, Zeynep Baran, et al.
Publicado: (2015)